In one SR on liver cancer, it showed beneficial effects of add-on with Aidi injection on ORR, KPS scores, survival rate, and immune function assessed by CD3 and CD4 compared to transarterial chemoembolization (TACE) treatment alone. Here, CD4 is linked to liver cancer.